No clinical supply request could be a higher priority than that of a physician urgently seeking an investigational cancer drug for a patient who has exhausted all treatment options.

This compelling case study outlines how a multinational pharmaceutical company worked with a cross-functional team at Fisher Clinical Services to deliver clinical supplies to treat an aggressive form of skin cancer called Merkel cell carcinoma.

These efforts resulted in the FDA fast tracking the investigational drug by granting it breakthrough status and early licensure as a commercial drug.